Detalhe da pesquisa
1.
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
J Transl Med
; 21(1): 174, 2023 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872371